{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:45:26Z","timestamp":1791639926866,"version":"4.3.4"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004853","name":"Chinese University of Hong Kong","doi-asserted-by":"crossref","award":["6905134 and 7101215"],"award-info":[{"award-number":["6905134 and 7101215"]}],"id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Drs. Richard Charles and Ester Yewpick Lee Charitable Foundation","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]},{"DOI":"10.13039\/501100004853","name":"Chinese University of Hong Kong","doi-asserted-by":"crossref","award":["6905134 and 7101215"],"award-info":[{"award-number":["6905134 and 7101215"]}],"id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Drs. Richard Charles and Ester Yewpick Lee Charitable Foundation","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>The Mayo clinic imaging classification allows more accurate risk stratification but is limited by the lack of data on non-White populations and on atypical imaging patterns.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>In this cohort of Chinese patients with autosomal dominant polycystic kidney disease, an atypical imaging pattern was observed in 17% of the cases, associated with later presentation and a milder disease course.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>There may be genotypic differences, especially among those with atypical imaging. Future genotyping studies will help to define the genetic basis for the phenotypic spectrum in Chinese patients.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The management of autosomal dominant polycystic kidney disease (ADPKD) remains challenging with variable and uncertain genotype\u2013phenotype correlations. The Mayo clinic imaging classification allows more accurate risk stratification but is limited by the atypical imaging patterns. We aim to assess the clinical characteristics and the morphology of the cystic kidneys in a cohort of Chinese patients with ADPKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Ninety-eight patients with ADPKD were recruited prospectively from August 2019 to December 2020 in Prince of Wales Hospital, Hong Kong. They were subsequently followed up every 6 months for a minimum of 2 years. We reviewed the clinical characteristics and magnetic resonance imaging patterns at baseline and the kidney outcome at the end of the follow-up. Atypical imaging patterns included unilateral, segmental, asymmetric, lopsided, and bilateral atrophy as defined by the Mayo Imaging Classification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean age was 51.5\u00b114.3 years, and the mean eGFR 68.7\u00b127.5 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      . The 98 patients included 36 male and 62 female. Seventy-six patients (77.6%) had a family history. Seventeen of the 98 (17.3%) patients had atypical imaging patterns. Compared with typical cases, atypical cases were older at the time of diagnosis (49.5\u00b116.0 versus 33.0\u00b113.0 years,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and at the time of starting antihypertensive medications (52.4\u00b114.8 versus 39.7\u00b111.0 years,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001) and were less likely to have a positive family history (58.8% versus 81.5%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.042). Patients with atypical patterns showed a lower eGFR decline compared with those with the typical pattern (\u22120.86\u00b14.34 versus \u22123.44\u00b14.07 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      per year,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.022).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this cohort of Chinese patients with ADPKD, an atypical imaging pattern was observed in 17% of the cases, associated with later presentation and a milder disease course. Future genotyping studies will help to define the genetic architecture and the basis for the phenotypic spectrum in Chinese patients with ADPKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.34067\/kid.0000000000000433","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:06:37Z","timestamp":1711929997000},"page":"715-723","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Clinical Characteristics and Kidney Outcomes in Chinese Patients with Autosomal Dominant Polycystic Kidney Disease"],"prefix":"10.34067","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7676-7628","authenticated-orcid":false,"given":"Winston Wing-Shing","family":"Fung","sequence":"first","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, China"},{"name":"CUHK Carol and Richard Yu Peritoneal Dialysis Research Centre, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8898-8505","authenticated-orcid":false,"given":"Cheuk-Chun","family":"Szeto","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, China"},{"name":"CUHK Carol and Richard Yu Peritoneal Dialysis Research Centre, Hong Kong, China"},{"name":"Li Ka Shing Institute of Health Sciences (LiHS), The Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5310-5197","authenticated-orcid":false,"given":"Kai-Ming","family":"Chow","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, China"},{"name":"CUHK Carol and Richard Yu Peritoneal Dialysis Research Centre, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis Mei-Shan","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, China"},{"name":"CUHK Carol and Richard Yu Peritoneal Dialysis Research Centre, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vickie Wai-Ki","family":"Kwong","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, China"},{"name":"CUHK Carol and Richard Yu Peritoneal Dialysis Research Centre, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0005-6878","authenticated-orcid":false,"given":"Sam Lik-Fung","family":"Lau","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, China"},{"name":"CUHK Carol and Richard Yu Peritoneal Dialysis Research Centre, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing-Fai","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, China"},{"name":"CUHK Carol and Richard Yu Peritoneal Dialysis Research Centre, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4962-4132","authenticated-orcid":false,"given":"Winnie Chiu-Wing","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7211-5400","authenticated-orcid":false,"given":"Albert Chee Meng","family":"Ong","sequence":"additional","affiliation":[{"name":"Academic Nephrology Unit, The University of Sheffield Medical School, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3744-4767","authenticated-orcid":false,"given":"Olivier","family":"Devuyst","sequence":"additional","affiliation":[{"name":"Institute of Physiology, University of Zurich, Z\u00fcrich, Switzerland"},{"name":"Division of Nephrology, UCLouvain Medical School, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9879-8388","authenticated-orcid":false,"given":"Philip Kam-Tao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, China"},{"name":"CUHK Carol and Richard Yu Peritoneal Dialysis Research Centre, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,4,1]]},"reference":[{"issue":"10","key":"B1-20250823","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1681\/ASN.2018050493","article-title":"Prevalence estimates of polycystic kidney and liver disease by population sequencing","volume":"29","author":"Lanktree","year":"2018","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"B2-20250823","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/j.ajkd.2015.07.037","article-title":"Autosomal dominant polycystic kidney disease: core curriculum 2016","volume":"67","author":"Chebib","year":"2016","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"B3-20250823","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","article-title":"Unified criteria for ultrasonographic diagnosis of ADPKD","volume":"20","author":"Pei","year":"2009","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"B4-20250823","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ekir.2019.04.018","article-title":"Intrafamilial variability of ADPKD","volume":"4","author":"Lanktree","year":"2019","journal-title":"Kidney Int Rep."},{"issue":"10","key":"B5-20250823","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1681\/ASN.2018060590","article-title":"A practical guide for treatment of rapidly progressive ADPKD with tolvaptan","volume":"29","author":"Chebib","year":"2018","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B6-20250823","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2013101138","article-title":"Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials","volume":"26","author":"Irazabal","year":"2015","journal-title":"J Am Soc Nephrol."},{"issue":"3","key":"B7-20250823","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.kint.2017.10.027","article-title":"Total kidney volume: the most valuable predictor of autosomal dominant polycystic kidney disease progression","volume":"93","author":"Xue","year":"2018","journal-title":"Kidney Int."},{"issue":"3","key":"B8-20250823","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.kint.2017.09.027","article-title":"Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in autosomal dominant polycystic kidney disease","volume":"93","author":"Yu","year":"2018","journal-title":"Kidney Int."},{"issue":"20","key":"B9-20250823","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease","volume":"354","author":"Grantham","year":"2006","journal-title":"N Engl J Med."},{"issue":"3","key":"B10-20250823","doi-asserted-by":"crossref","first-page":"e92232","DOI":"10.1371\/journal.pone.0092232","article-title":"Clinical characteristics and disease predictors of a large Chinese cohort of patients with autosomal dominant polycystic kidney disease","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One."},{"issue":"9981","key":"B11-20250823","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(15)60907-2","article-title":"Autosomal dominant polycystic kidney disease: the changing face of clinical management","volume":"385","author":"Ong","year":"2015","journal-title":"Lancet."},{"issue":"suppl 4","key":"B12-20250823","doi-asserted-by":"crossref","first-page":"iv26","DOI":"10.1093\/ndt\/gfu091","article-title":"Building a network of ADPKD reference centres across Europe: the EuroCYST initiative","volume":"29","author":"Petzold","year":"2014","journal-title":"Nephrol Dial Transplant."},{"issue":"9","key":"B13-20250823","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.ekir.2023.06.018","article-title":"Clinical characteristics of rapid progression in asia-Pacific patients with ADPKD","volume":"8","author":"Oh","year":"2023","journal-title":"Kidney Int Rep."},{"issue":"3","key":"B14-20250823","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000506288","article-title":"Executive summary: clinical practice guideline for autosomal dominant polycystic kidney disease in China","volume":"6","author":"Mei","year":"2020","journal-title":"Kidney Dis (Basel)."},{"issue":"1","key":"B15-20250823","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41525-022-00309-w","article-title":"PKD2 founder mutation is the most common mutation of polycystic kidney disease in Taiwan","volume":"7","author":"Yu","year":"2022","journal-title":"NPJ Genom Med."},{"issue":"7","key":"B16-20250823","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1681\/ASN.2019101121","article-title":"Expanded imaging classification of autosomal dominant polycystic kidney disease","volume":"31","author":"Bae","year":"2020","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"B17-20250823","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1053\/j.ajkd.2015.01.030","article-title":"Total kidney volume in autosomal dominant polycystic kidney disease: a biomarker of disease progression and therapeutic efficacy","volume":"66","author":"Alam","year":"2015","journal-title":"Am J Kidney Dis."},{"issue":"9569","key":"B18-20250823","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet."},{"issue":"6","key":"B19-20250823","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.ajhg.2016.05.004","article-title":"Mutations in GANAB, encoding the glucosidase II\u03b1 subunit, cause autosomal-dominant polycystic kidney and liver disease","volume":"98","author":"Porath","year":"2016","journal-title":"Am J Hum Genet."},{"issue":"1","key":"B20-20250823","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s13023-020-01585-4","article-title":"Novel GANAB variants associated with polycystic liver disease","volume":"15","author":"van de Laarschot","year":"2020","journal-title":"Orphanet J Rare Dis."},{"issue":"6","key":"B21-20250823","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/ckj\/sfac032","article-title":"More dissimilarities than affinities between DNAJB11-PKD and ADPKD","volume":"15","author":"Pisani","year":"2022","journal-title":"Clin Kidney J."},{"issue":"8","key":"B22-20250823","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.ajhg.2022.06.013","article-title":"Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis","volume":"109","author":"Lemoine","year":"2022","journal-title":"Am J Hum Genet."},{"issue":"11","key":"B23-20250823","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1681\/ASN.2019030298","article-title":"ALG9 mutation carriers develop kidney and liver cysts","volume":"30","author":"Besse","year":"2019","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B24-20250823","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ajhg.2021.11.016","article-title":"Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype","volume":"109","author":"Senum","year":"2022","journal-title":"Am J Hum Genet."},{"issue":"5","key":"B25-20250823","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2215\/CJN.02320220","article-title":"Insights into autosomal dominant polycystic kidney disease from genetic studies","volume":"16","author":"Lanktree","year":"2021","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"B26-20250823","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.kint.2019.08.038","article-title":"Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease","volume":"97","author":"Hopp","year":"2020","journal-title":"Kidney Int."},{"issue":"4","key":"B27-20250823","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3390\/genes5041064","article-title":"Somatic mosaicism in the human genome","volume":"5","author":"Freed","year":"2014","journal-title":"Genes (Basel)."},{"issue":"7","key":"B28-20250823","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.tig.2015.03.013","article-title":"Somatic mosaicism: implications for disease and transmission genetics","volume":"31","author":"Campbell","year":"2015","journal-title":"Trends Genet."},{"issue":"2","key":"B29-20250823","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.kint.2019.11.019","article-title":"Next-generation sequencing for detection of somatic mosaicism in autosomal dominant polycystic kidney disease","volume":"97","author":"Devuyst","year":"2020","journal-title":"Kidney Int."},{"issue":"9","key":"B30-20250823","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1681\/ASN.2016090938","article-title":"Polycystic kidney disease without an apparent family history","volume":"28","author":"Iliuta","year":"2017","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"B31-20250823","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ajhg.2018.03.013","article-title":"Monoallelic mutations to DNAJB11 cause atypical autosomal-dominant polycystic kidney disease","volume":"102","author":"Cornec-Le Gall","year":"2018","journal-title":"Am J Hum Genet."},{"issue":"1","key":"B32-20250823","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1681\/ASN.2017050483","article-title":"Genetic complexity of autosomal dominant polycystic kidney and liver diseases","volume":"29","author":"Cornec-Le Gall","year":"2018","journal-title":"J Am Soc Nephrol."},{"issue":"8","key":"B33-20250823","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/s41436-020-0816-3","article-title":"Matching clinical and genetic diagnoses in autosomal dominant polycystic kidney disease reveals novel phenocopies and potential candidate genes","volume":"22","author":"Sch\u00f6nauer","year":"2020","journal-title":"Genet Med."},{"issue":"24","key":"B34-20250823","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1001\/jama.2022.22847","article-title":"Exome sequencing of a clinical population for autosomal dominant polycystic kidney disease","volume":"328","author":"Chang","year":"2022","journal-title":"JAMA."},{"issue":"8","key":"B35-20250823","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s40620-022-01286-0","article-title":"Estimated GFR in autosomal dominant polycystic kidney disease: errors of an unpredictable method","volume":"35","author":"Rodr\u00edguez","year":"2022","journal-title":"J Nephrol."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000000000433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:00:19Z","timestamp":1786478419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000000000433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000000000000433","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,1]]},"assertion":[{"value":"2023-09-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}